Article info
Editorial
Early stopping of a randomised trial for efficacy: a medical, ethical and regulatory challenge
- Correspondence to Dr Arthur Darmon, Department of Cardiology, Assistance Publique - Hopitaux de Paris, 75004 Paris, France; arthur.darmon{at}gmail.com
Citation
Early stopping of a randomised trial for efficacy: a medical, ethical and regulatory challenge
Publication history
- First published May 21, 2021.
Online issue publication
June 25, 2021
Article Versions
- Previous version (21 May 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.